Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001088796 | SCV000560282 | likely benign | Hereditary breast ovarian cancer syndrome | 2022-10-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000827083 | SCV000968699 | likely benign | not provided | 2020-11-09 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 30209399) |
Ambry Genetics | RCV001010350 | SCV001170532 | likely benign | Hereditary cancer-predisposing syndrome | 2015-10-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV001010350 | SCV001347270 | likely benign | Hereditary cancer-predisposing syndrome | 2018-11-05 | criteria provided, single submitter | clinical testing | |
Brotman Baty Institute, |
RCV001076998 | SCV001242855 | not provided | Breast-ovarian cancer, familial, susceptibility to, 1 | no assertion provided | in vitro | ||
Genetic Services Laboratory, |
RCV003151073 | SCV003839262 | likely benign | not specified | 2022-07-27 | no assertion criteria provided | clinical testing |